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Background: Substance-related deaths account for a great number of suicides. 
 
Aim: To investigate levels and characteristics of suicide verdicts, as opposed to accidental deaths, in 
substance misusers.  
Methods: Psychological autopsy study of cases from the UK National Programme on Substance 
Abuse Deaths (np-SAD) during the period 2001-2007. 
Results: Between January 2001 and December 2007, 2108 suicides were reported to the np-SAD. 
Typical suicide victims were White and older than 50 (respectively 95% and 41% of cases). 
Medications, especially antidepressants (44%), were prescribed to 87% of victims. Significantly 
fewer suicides than controls presented with positive blood toxicological results for illicit drugs 
(namely: cocaine, heroin, amphetamines, ecstasy-type drugs, cannabis, GHB/GBL, etc.) and 
alcohol. 
Conclusions: Suicide prevention programmes should devote specific attention to deaths among 
substance misusers who are at high risk of fatal intentional self-harm. Specific characteristics 
distinguish those at risk; caregivers should be better educated as to what these factors are. 
Limitations of the current study included lack of provision of comprehensive information relating to 
the victims’ psychosocial variables. Furthermore, no differentiation between within class different 
antidepressants in terms of involvement in suicide was here provided.   
Keywords: Substance Abuse, Suicide, Accidental deaths, United Kingdom, Antidepressants. 
 
Abbreviations: np-SAD, UK National Programme on Substance Abuse Deaths; χ2, chi-square tests; 
OR, Odds Ratios. 
 
1. Introduction 
Substance misuse is a major cause of disability, and drug-related deaths account for a 
sizeable percentage of all deaths in this population (Ghodse et al., 2010). Comorbidity between 
substance abuse and psychiatric disorders is a matter of great concern; both conditions are 
reportedly linked to increased suicide risk (Ghodse et al., 2009; Harris and Barraclough, 1997; 
Hawton and van Heeringen, 2009). Findings from the UK confirm that addicts are still at higher 
risk of suicide than the general population and that prescribed drugs, notably antidepressants and 
methadone, are associated with a heightened risk (Oyefeso et al., 1999). In the UK, the National 
Programme on Substance Abuse Deaths (np-SAD; Ghodse et al., 2010), constitutes a strategic 
observatory of the phenomenon with key strategic opportunities. Although suicide is particularly 
represented in substance abusers, little is known about the role of psychoactive substances’ self 
administration as a suicidal method.  
The aims of the present study were to investigate substance abuse deaths due to suicide and 
to characterise this population as compared to other causes of death. Using the above-mentioned 
National Registry we aimed to examine the pattern of all reported overdose suicides in this UK 
population during a specific time-frame. 
2. Methods 
This 7-year (January 2001 to December 2007) retrospective study reports on cases from the 
np-SAD, located at St. George’s, University of London. The np-SAD was established after the 
Home Office Addicts Index closed in 1997 and, since then, it has regularly received information 
from coroners on a voluntary basis on deaths related to drugs in both addicts and non-addicts in 
England and Wales, Northern Ireland, the Channel Islands and the Isle of Man. Since 2004, 
information has been received from the Scottish Crime and Drug Enforcement Agency and the 
General Register Office for Northern Ireland. To date, details of some 23,000 deaths have been 
received. To be recorded in the np-SAD database as a drug-related death, at least one of the 
following criteria must be met: (a) presence of one or more psychoactive substances directly 
implicated in death; (b) history of dependence or abuse of drugs; and (c) presence of controlled 
drugs at post-mortem. Deaths that occurred outside the UK are excluded, so that the information is 
comparable with the statistics from the UK General Mortality registers. The response rate from 
coroners in England and Wales during the period examined ranged from 89% to 95%. However, 
often further information is submitted eventually and appropriately added to the database, so that 
the resulting coroners’ compliance rates are higher. All cases notified have been included in these 
analyses. 
We selected all consecutive cases of drug-related deaths from the np-SAD database that 
occurred in the UK between January 2001 and December 2007 and where death was unequivocally 
classified as suicide by Coroners. Excluded were all presumed suicides for which information was 
unclear or missing in respect of intention, e.g. no ‘suicide note’. Controls were all consecutive cases 
of drug-related deaths from np-SAD database that died in the UK during the same time-frame, and 
whose manner of death was classified as accidental by Coroners. A total of 2108 files fulfilling 
inclusion criteria were retrieved and were selected for the suicide group. Some 4096 files were 
retrieved and were selected as controls for the study. 
The information was gathered through review of medical and social history, post-mortem 
examination, and toxicological evaluation. We extracted socio-demographic variables (age, gender, 
ethnicity, employment status, living arrangements), and reports of the presence of drug use 
disorders, prescribed medication, and psychoactive substances at the toxicological examination. 
Toxicological analyses were performed on blood, urine, or other matrices. Typical toxicology post 
mortem screening was for ethanol and other volatiles, as well as for a wide variety of prescription, 
and illicit drugs commonly used or abused in the UK.  
A verdict of suicide requires "some evidence that the deceased intended to take his own life" 
meaning that open verdicts are often recorded in cases where suicide is suspected but the evidence 
of intent is lacking. A number of studies reported (Cooper and Milroy, 1995; Lindqvist and 
Gustafsson, 2002; Linsley et al., 2001; Parai et al., 2006; Platt et al., 1988; Salib, 1996) that deaths 
from hanging and gas were more likely to be assigned as suicide, whereas deaths from poisoning 
and drowning were less likely to be so assigned.  
Chi-square tests with Yates’s correction (χ2) and one-way Fisher exact tests were used to 
analyze N x N contingency tables; t-tests were used to analyse differences between groups on 
dimensional variables. Bonferroni’s correction was used to correct for multi-testing. Log-linear 
modelling analysis was employed to determine multivariate associations between variables 
significant at the level of bivariate analyses. Because the computing limitation was 9 variables, 
separate analyses were carried out. Likelihood ratio χ2 as measure of fit of the model; Odds Ratios 
(OR) and log-OR as measure of association are reported here. All statistical analyses were 
performed using the SPSS
TM
 for Windows statistical software package Version 13.0. 
3. Results 
Sociodemographic characteristics for the 2108 suicide cases are listed in Table 1. Around 
61% of the suicide victims were males. Suicide victims were aged 13 to 97 years (mean=47.66; 
SD=17.42), and around 95% were White (where ethnicity was known). 
People who died from suicide and controls that died from accidental causes differed on 
several variables (see Table 2). Suicide victims were more likely to be older (47.7±17.4 vs. 
36.1±11.9; tDF=3145.92=27.27; p<0.001), and female (39% vs. 22%; p<0.001). Furthermore, they 
differed in terms of both employment status (χ2df=3=604.39; p< 0.001), and living arrangements 
(χ2df=2=96.41; p<0.001). More suicide victims were either retired/invalid/sick (26.4% vs. 6.2%), or 
employed (36.0% vs. 30.8%) than those people whose death was accidental. These results may be 
associated with the older age of the suicide victims (17.5% of suicide victims were 65+ years old 
vs. only 2.8% of controls). Also, compared to controls, fewer suicide victims were addicted to illicit 
drugs (only 29% vs. 80%; p<0.001), whilst more suicide victims were prescribed with medications 
(87% vs. 70%; p<0.001). 
When comparing groups for categories of prescribed psychoactive drugs, groups were 
different for all categories except for anti-epileptics (p=0.09), anti-Parkinson (p=0.32), and 
amphetamines (p= 0.36; after correction for multi-testing). Suicide victims (compared to accidental 
deaths) were more likely to have been prescribed hypnotics/sedatives (28% vs. 23%; p<0.001), 
antidepressants (44% vs. 20%; p<0.001), antipsychotics (13% vs. 9%; p<0.001), and other 
opiates/opioid analgesics (21% vs. 11%; p<0.001), and they were less likely to have been 
prescribed methadone (2% vs. 9%; p<0.001). 
When assessing types of prescribed antidepressants, 38.5% and 26.8%, respectively of 
suicide victims and accidental deaths were prescribed tricyclic antidepressants (p<0.001); 39.3% 
and 46.2%%, respectively of suicide victims and accidental deaths were prescribed selective 
serotonin reuptake inhibitors (SSRIs) (p<0.01); whilst respectively 16.0% and 9.9% of suicide 
victims and accidental deaths were prescribed venlafaxine (p<0.001). Conversely, suicide victims 
and accidental deaths did not differ in terms of prescription rates of the following drugs: inhibitors 
of monoamino-oxidase (IMAOs); mirtazapine; and trazodone. 
When investigating toxicological results (Table 2), groups differed for all categories of 
substances investigated except for hypnotics/sedatives; anti-epileptics; and anti-Parkinson. More 
suicide victims than controls had positive toxicological results for antidepressants (38% vs. 14%; 
p<0.001), antipsychotics (6% vs. 3%; p<0.001), and barbiturates (2% vs. 0.4%; p<0.001); and 
fewer suicide victims than controls had positive toxicological results for an illicit drug (54% vs. 
76%; p<0.001), alcohol (25% vs. 39%; p<0.001), and methadone (4% vs. 18%; p<0.001). In suicide 
victims, in comparison with accidental deaths, SSRIs were less frequently (respectively:  24.8% vs 
29.5%; p<0.05); and venlafaxine more frequently (12.9% vs 9.4%; p<0.05) identified at post 
mortem toxicological analyses. 
To evaluate multivariate associations between variables several log-linear analyses were 
performed, with the groups (suicide vs. accidental deaths) as the dependent variable, and all the 
variables significant at the bivariate analyses after correction for multiple testing as independent 
variables (see Table 3). The first model tested (group x [gender, drug addiction status, age bands, 
living arrangements, employment status, and the presence or not of any prescribed medication]) 
fitted the data well (Likelihood Ratio χ2=243.45 [DF=372]; p=1.00). Suicide victims were 1.4 times 
more likely to be older adults (p<0.05) than accidental deaths. They were also more likely to have 
been prescribed any medication (OR=2.2; p<0.001), and less likely to be unemployed (OR=0.6; 
p<0.05) or to have been formally identified as drug addicts (OR=0.1; p<0.001), than accidental 
deaths.  
For any single category of drugs prescribed and substances implicated at the toxicological 
analysis, we performed two independent log-linear analyses, and then all the variables significantly 
associated with death groups were entered into a final model. The final model fitted the data well 
(Likelihood Ratio χ2=338.93 [DF=502]; p=1.00). Groups differed on all the variables entered; more 
in particular: a) suicidal victims were more likely to have been prescribed antidepressants (OR=1.7; 
p<0.001), and opiates (OR=2.4; p<0.001), and less likely to have been prescribed 
hypnotics/sedatives (OR=0.8; p<0.05), and methadone (OR=0.6; p<0.01) than accidental deaths; 
and b) more suicide victims had positive toxicological results for antidepressants (OR=1.9; 
p<0.001), and barbiturates (OR=3.3; p<0.001), and less positive toxicological results for an illicit 
drug (OR=0.4; p<0.001), alcohol (OR=0.6; p<0.001), and methadone (OR=0.2; p<0.001) than 
accidental deaths.  
4. Discussion 
This study sought to characterise suicide among drug-related deaths. Notably, a 
considerable number of variables significantly identified suicides when compared to other causes of 
death among substance-related deaths.  
Our study identified that specific sociodemographic characteristics are important in 
identifying suicide victims, as they were more likely to be older and female. More suicide victims 
had a medical or economic problem than those people whose death was accidental, although this 
may be partly explained by the older age of the suicide victims. 
Also, compared to controls, fewer suicide victims had been formally identified as dependent 
on illicit drugs, while more suicide victims were prescribed medication. More specifically, suicide 
victims (compared to accidental deaths) were more likely to have been prescribed 
hypnotic/sedatives, antidepressants, antipsychotics, and other opiates/opioid analgesics, and they 
were less likely to have been prescribed methadone. 
Toxicological results confirmed that more suicide victims than controls were positive for 
psychotropic drugs, and fewer suicide victims than controls had positive results for illicit drugs, 
alcohol, and methadone. The higher rate of prescription/positive blood test of psychotropics among 
suicides than among non suicides may not be considered surprising, as suicides have more 
frequently psychiatric illness(es). It has been recently confirmed (Isaccson et al, 2010) that 
antidepressant prescription may well be associated with suicide prevention in depression. Since the 
length of psychotropic drug treatment before suicide was not made available for the current 
analysis, one could speculate that most suicide victims with positive blood test of psychotropics 
were in the early stage of the treatment or were non responders. 
           Comparing with the higher lethality levels of first generation antidepressants (Beaumont, 
1989; Reseland et al., 2006), the introduction of serotonergic agents was reported as a breakthrough 
in the reduction of suicide rates when drugs were used to precipitate suicide (Grunebaum et al., 
2004; Isacsson, 2000). In line with this, and consistent with Cheeta et al (2004) observations in 
suicide victims, in comparison with accidental deaths, SSRIs were less frequently (p<0.05); and 
venlafaxine more frequently (p<0.05) identified at post mortem toxicological analyses.  
           In a comprehensive overview of deaths related to analgesic- and cough suppressant-opioids 
in England and Wales during the period 1996–2002, Schifano et al. (2006) found that most (83%) 
addicts died as a result of accidental deaths. Conversely, the number of intentional poisoning cases 
was considerably high (46 %) in non-addicts. Antidepressant- and dextropropoxyphene-containing 
compounds were mostly represented in non-addicts’ intentional deaths. Dextropropoxyphene was 
arguably prescribed for pain control and one might hypothesize a possible association between 
chronic pain and depression, which may in turn have led to suicide (Schifano et al., 2006). Even the 
psychiatric co-morbidity and antidepressant prescription issues may deserve further investigation in 
accidental deaths (Holding and Barraclough, 1977). 
In the past, suicide caused great stigmatisation, and death certification could be left 
deliberately inaccurate due to the need to conceal the act (Seabourne and Seabourne, 2001). 
Although stigmatisation towards suicide still exists (Pompili et al., 2003; Pompili et al,, 2004), there 
is a growing need to report causes of death correctly. Although this may be a controversial issue 
(Ohberg and Lonnqvist, 1998), in 1978 Holding and Barraclough demonstrated that most 
undetermined deaths in the UK population were not suicides as previously hypothesized.
 
 Our study has a number of limitations that should be taken into account. Firstly, it did not 
involve a thorough psychological autopsy approach, which would have added important 
information about the psychosocial characteristics of the deceased. In fact, a psychological autopsy 
helps to clarify an equivocal death by interviewing people who knew the deceased individual 
(spouse, grown children, neighbours, employers, or physicians) and by analysing his/her clinical 
records. Despite this limitation, the current investigation may still shed some light on both the 
mechanics and the characteristics of suicidal events in substance misusers. Furthermore, as Hawton 
and colleagues (2010) recently reported, there are wide differences in toxicity not only between 
classes of antidepressants but also within classes, therefore future studies should consider the 
involvement in fatalities of specific molecules, not just of drug classes. Again, levels of blood 
toxicology results (e.g., low/therapeutic/toxic level) were here unfortunately not always provided by 
Coroners. Finally, different from the approach taken here, it has been suggested that deaths 
receiving an ‘open’ verdict should be included in all suicide research after excluding cases in which 
suicide was unlikely (Linsley et al, 2001). 
It is concluded that suicide prevention programmes should devote specific attention to deaths 
among substance misusers who are at high risk of fatal intentional self-harm. Specific 
characteristics may distinguish those at risk; caregivers should be better educated as to what these 
factors are (Baca-Garcia et al., 2007; Nordentoft, 2010). 
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Table 1 
Sociodemographic characteristics of suicide victims 
 Suicide victims 
N 2108 
Part of UK where death occurred  
England 95.6% 
Wales 3.1% 
Guernsey 0.1% 
Jersey 0.9% 
Isle of Man 0.2% 
Men 60.8% 
Age - Mean±SD 47.66±36.13 
Ethnicity  
White 95.1% 
Black Carribean 0.7% 
Black African 0.6% 
Black Other 0.4% 
Indian 0.7% 
Pakistani 0.6% 
Bangladeshi 0.0% 
Chinese 0.1% 
Other 1.9% 
 
Table 2 
Differences between groups 
Variables Suicide 
victims 
(N=2108) 
Accidental 
deaths 
(N=4096) 
Test P-value 
Males 60.8% 78.4%  0.001 
Age 47.66±17.42 36.13±11.90  tDF=3145.92=27.27 0.001 
Ethnicity   χ
2
df=8=11.54 0.17 
White 95.1% 95.1%  0.50 
Others 4.9% 4.6%   
Employment status   χ
2
df=3=604.39 0.001 
Unemployed 32.1% 58.5%   
Employed 36.0% 30.8%   
Retired/invalidity/sickness 26.4% 6.2%   
Other 5.5% 4.5%   
Living arrangements   χ
2
df=2=96.41 0.001 
With others 47.3% 48.1%   
Alone 48.5% 40.5%   
Other 4.2% 11.4%   
Drug addiction 28.7% 79.7%  0.001 
Prescribed medication 87.4% 69.8%  0.001 
Hypnotics/sedatives 28.1% 23.4%  0.001 
Antidepressants 43.6% 19.5%  0.001 
Antipsychotics 13.1% 9.2%  0.001 
Antiepileptics 5.3% 4.5%  0.09 
Anti-Parkinsons 1.6% 1.4%  0.32 
Heroin/morphine 2.5% 1.6%  0.009 
Other opiates/opioid analgesics 21.4% 11.2%  0.001 
Methadone 2.3% 9.2%  0.001 
Amphetamines 0.1% 0.2%  0.36 
Positive blood toxicological results for    
Any illicit drug 53.8% 76.3%  0.001 
Alcohol 25.4% 38.6%  0.001 
Methadone 3.5% 17.9%  0.001 
Antidepressants 37.6% 13.7%  0.001 
Hypnotics/sedatives 22.1% 21.3%  0.27 
Antipsychotics 5.5% 2.7%  0.001 
Antiepileptics 2.8% 1.7%  0.005 
Anti-Parkinsons 0.5% 0.5%  0.46 
Barbiturates 1.5% 0.4%  0.001 
Multi-testing correction: Bonferroni p-value= 0.10/25=0.004  
 
 Table 3 
Loglinear Models 
Model Parameter 
OR 
Log-
OR 
P< 
1 Suicide victims * Men 1.00 0.004 0.97 
 Suicide victims * Drug addiction 0.14 -1.94 0.001 
 Suicide victims * Adolescents 0.69 -0.37 0.48 
 Suicide victims * Young Adults (<35 years old) 0.79 -0.24 0.01 
 Suicide victims * Older adults (65+ years old) 1.41 0.35 0.05 
 Suicide victims * Living with others 1.19 0.18 0.35 
 Suicide victims * Living alone 1.31 0.27 0.15 
 Suicide victims * Unemployed 0.62 -0.48 0.05 
 Suicide victims * Employed 1.17 0.16 0.43 
 Suicide victims * Retired/invalidity/sickness 1.22 0.20 0.37 
 Suicide victims * Prescribed medication 2.23 0.80 0.001 
2 Suicide victims * Positive blood toxicological results 
for any illicit drug 
0.39 -0.93 0.001 
 Suicide victims * Positive blood toxicological results 
for Alcohol 
0.55 -0.61 0.001 
 Suicide victims * Positive blood toxicological results 
for Antidepressants 
2.61 0.96 0.001 
 Suicide victims * Positive blood toxicological results 
for Antipsychotics 
1.08 0.08 0.60 
 Suicide victims * Positive blood toxicological results 3.03 1.11 0.001 
for Barbiturates 
 Suicide victims * Positive blood toxicological results 
for Methadone 
0.14 -1.97 0.001 
3 Suicide victims * Antidepressants prescribed 2.97 1.09 0.001 
 Suicide victims * Antipsychotics prescribed 1.16 0.15 0.11 
 Suicide victims * Hypnotics/sedatives prescribed 0.87 -0.14 0.05 
 Suicide victims * Methadone prescribed 0.29 -1.24 0.001 
 Suicide victims * Opiates prescribed 1.84 0.61 0.001 
4 Suicide victims * Positive blood toxicological results 
for any illicit drug 
0.35 -1.05 0.001 
 Suicide victims * Positive blood toxicological results 
for Alcohol 
0.56 -0.57 0.001 
 Suicide victims * Positive blood toxicological results 
for Antidepressants 
1.91 0.65 0.001 
 Suicide victims * Positive blood toxicological results 
for Barbiturates 
3.26 1.18 0.001 
 Suicide victims * Positive blood toxicological results 
for Methadone 
0.17 -1.75 0.001 
 Suicide victims * Positive blood toxicological results 
for Antidepressants 
1.69 0.52 0.001 
 Suicide victims * Positive blood toxicological results 
for Hypnotics/sedatives 
0.84 -0.18 0.05 
 Suicide victims * Positive blood toxicological results 
for Methadone 
0.62 -0.47 0.01 
 Suicide victims * Positive blood toxicological results 2.38 0.87 0.001 
for Opiates 
Models fit statistics Likelihood 
Ratio χ2 
DF P< 
1  243.45 372 1.00 
2  65.10 57 0.22 
3  101.80 26 0.001 
4  338.93 502 1.00 
 
 
 
 
